Jonathan Webster - Dissemin

All papers authored by Jonathan Webster

This paper is made freely available by the publisher.

2023 Jonathan A. Webster

, Leo Luznik

This CAR won’t start: predicting nonresponse in ALL

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Karin Miller, Jonathan Webster

, Philip Imus

, Candice Ament, Melanie Hardy, Ying S. Zou

Detection of an atypical BCR::ABL1 fusion in a patient with secondary B-cell acute lymphoblastic leukemia/lymphoma following multiple myeloma treatment

Upload

Jonathan A. Webster

, Madison Reed

, Hua-Ling Tsai, Alexander Ambinder

, Tania Jain

, Amy E. Dezern, Mark J. Levis, Margaret M. Showel, Gabrielle T. Prince, Christopher S. Hourigan, Douglas E. Gladstone, Javier Bolanos-Meade, Lukasz P. Gondek, Gabriel Ghiaur

, W. Brian Dalton

and 15 other authors

Allogeneic Blood or Marrow Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Acute Lymphoblastic Leukemia in Patients Age ≥55 Years

Upload

Distributing this paper is prohibited by the publisher

Khaled Sanber

, Kevin Ye, Hua-Ling Tsai, Matthew Newman, Jonathan A. Webster

, Ivana Gojo, Gabriel Ghiaur, Gabrielle T. Prince, Lukasz P. Gondek, B. Douglas Smith, Mark J. Levis, Amy E. DeZern, Alexander J. Ambinder, William B. Dalton

, Tania Jain

Venetoclax in combination with hypomethylating agent for the treatment of advanced myeloproliferative neoplasms and acute myeloid leukemia with extramedullary disease

Upload

2022 Theodoros Karantanos, Hua-Ling Tsai, Lukasz P. Gondek, Amy E. DeZern, Gabriel Ghiaur, W. Brian Dalton

, Ivana Gojo, Gabrielle T. Prince, Jonathan Webster

, Alexander Ambinder, B. Douglas Smith, Mark J. Levis, Ravi Varadhan, Richard J. Jones, Tania Jain

Genomic landscape of myelodysplastic/myeloproliferative neoplasm can predict response to hypomethylating agent therapy

Upload

2021 Jonathan A. Webster

, Meera Yogarajah, Marianna Zahurak, Heather Symons, Amy E. Dezern, Ivana Gojo, Gabrielle T. Prince, Jillian Morrow, Richard J. Jones, B. Douglas Smith, Margaret Showel

A phase II study of azacitidine in combination with granulocyte-macrophage colony-stimulating factor as maintenance treatment, after allogeneic blood or marrow transplantation in patients with poor-risk acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS)

Upload

Husheng Ding, Nicole D. Vincelette, Cordelia D. McGehee, Mira A. Kohorst, Brian D. Koh, Annapoorna Venkatachalam, X. Wei Meng, Paula A. Schneider, Karen S. Flatten, Kevin L. Peterson, Cristina Correia

, Sun-Hee Lee, Mrinal Patnaik, Jonathan A. Webster

, Gabriel Ghiaur and 6 other authors

CDK2-mediated upregulation of TNFa as a mechanism of selective cytotoxicity in acute leukemia

Upload

2020 Jonathan A. Webster

, Leo Luznik, Hua-Ling Tsai, Philip H. Imus, Amy E. DeZern, Keith W. Pratz, Mark J. Levis

, Ivana Gojo, Margaret M. Showel, Gabrielle Prince, Javier Bolaños-Meade, Lukasz P. Gondek, Gabriel Ghiaur

, W. Brian Dalton

, Tania Jain

and 11 other authors

Allogeneic transplantation for Ph+ acute lymphoblastic leukemia with posttransplantation cyclophosphamide

Download from doi.org

Cole Sterling, Jonathan Webster

“Harnessing the Immune System After Allogeneic Stem Cell Transplant in Acute Myeloid Leukemia”

Download from api.wiley.com

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Jonathan Webster